Nimesulide is used to treat pain, inflammation and fever. It is classified as a cyclooxygenase 2 inhibitor (COX-2) selective non-steroidal anti-inflammatory drug (NSAID). Nimesulide is not approved for use in the U.S. due to concerns about the risk of serious liver toxicity. Nimesulide has ...
Individual Impurity≤0.1% Total Impurity≤0.5% Use Pharmaceutical APIs, nimesulide is used in non-steroidal anti-inflammatory drugs and antipyretic Packing 25kg/fiber drum keep tighly in dry place, it is available for 3 years < Back >QR
Nimesulide is not used in the U.S. Finland, Spain, Portugal and Israel. These countries and other European countries have withdrawn the pediatric formulation of nimesulide. The drug was never licensed for use in Canada, Britain and Australia. The continuing use of nimesulide in India is ...
“The oral preparation Nimesulide is banned for children under the age of 12. It can only be used as a kind of second line medicine when at least one kind of non-steroidal anti-inflammatory drug fails in treatment.”
There is very little data available concerning the metabolism and distribution of nimesulide, which is of some concern. Therapeutic Trials Nimesulide has been used in a number of studies in patients with a variety of inflammatory diseases and pain states. Unfortunately, documentation within each ...
The invention disclosed in this application relates to a nimesulide controlled release pharmaceutical composition.The composition is used for tretment of inflammatory conditions and for removal of pains,the dosage is effective for a period of 18.0 to 24.0 hours thereby reducing the dose of the drug,...
The invention disclosed in this application relates to a nimesulide controlled release pharmaceutical composition.The composition is used for tretment of inflammatory conditions and for removal of pains,the dosage is effective for a period of 18.0 to 24.0 hours thereby reducing the dose of the drug,...
Nimesulide is non-steroidal anti-inflammatory drug that is widely used in medical practice and characterized by low solubility. One of solubility modifying method for pharmaceutical substances is preparation of solid dispersions based on macromolecular compounds. The aim is to explore the mechanisms of ...
Pref. the cyclodextrin is of beta-type and. USE/ADVANTAGE - (I) shows improved bioavailability and increase the max. plasma concn. of the nimesulid, which is an antiphlogistic used in the treatment of articular and extraarticular inflammations and is very sparingly soluble and of low ...
Pref. the cyclodextrin is of beta-type and. USE/ADVANTAGE - (I) shows improved bioavailability and increase the max. plasma concn. of the nimesulid, which is an antiphlogistic used in the treatment of articular and extraarticular inflammations and is very sparingly soluble and of low ...